Apiam Animal Health Limited

Apiam Animal Health Limited

AHX.AX
Apiam Animal Health LimitedAU flagAustralian Securities Exchange
0.88
AUD
+0.01
- -
164.41MMarket Cap
Apiam Animal Health Limited
AHX.AX
(Australian Securities Exchange)

Recent

price

0.88

P/E

ratio

- -

div

yld

- -

ROIC.AI

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
- -
0.9
0.96
1.03
1.05
1.03
1.03
1.16
1.1
1.15
- -
Revenue per Share
- -
- -
0.05
0.03
0.03
0.04
0.04
0.03
0.01
0.03
- -
Basic EPS, GAAP
- -
-0.01
-0.02
-0.05
-0.02
-0.02
-0.04
-0.04
-0.05
-0.03
- -
Free Cash Flow per Basic Share
- -
- -
0.01
0.01
0.01
0.01
0.02
0.02
- -
0.01
- -
Dividend per Share
0.78
1.31
0.85
0.88
0.88
0.88
0.92
1.04
0.86
0.86
- -
Book Value per Share
-0.01
0.03
-0.03
-0.06
-0.04
-0.14
-0.12
-0.13
-0.26
-0.26
- -
Tangible Book Value per Share
98
60
102
104
107
115
122
136
175
179
- -
Basic Weighted Avg Shares
- -
54
98
107
112
118
126
157
192
205
207
Sales/Revenue/Turnover
- -
2.78
6.11
5.36
5.08
6.56
6.56
6.1
3.43
6.04
6.01
Operating Margin (%)
- -
1
1
2
3
6
6
8
10
12
13
Depreciation Expense
- -
- -
5
3
3
4
5
5
2
5
1
Net Income, GAAP
- -
91.29
20.03
31.98
31.06
29.25
28.99
29.85
31.43
30.5
69.79
Effective Tax Rate (%)
- -
0.09
5.13
3.08
2.83
3.52
4.03
2.95
1.19
2.41
0.4
Profit Margin (%)
8
6
10
7
9
7
9
7
1
-1
-2
Working Capital
13
12
22
23
23
45
49
57
90
96
97
LT Debt
45
46
54
59
61
69
81
109
118
122
121
Total Equity
- -
0.21
6.62
4.64
4.47
5.25
4.55
4.32
2.31
3.89
1.67
Return on Invested Capital (%)
- -
0.05
5.41
3.3
3.26
3.47
3.58
2.98
2.02
3.2
0.82
Return on Capital (%)
- -
0.06
6.05
3.67
3.42
4.3
4.77
3.66
1.56
3.24
0.54
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.76%
12.73%
-0.79%
Free Cash Flow
- -
43.29%
39.98%
Net Income, GAAP
- -
-0.87%
-83.13%
Sales/Revenue/Turnover
- -
12.21%
1.11%
Total Cash Common Dividend
- -
41.63%
97.5%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
192
2024
- -
- -
- -
- -
205
2025
- -
- -
- -
- -
207

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.01
2024
- -
- -
- -
- -
0.03
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
0.01
2025
- -
- -
- -
- -
- -
Business
Apiam Animal Health Limited stands as a vertically integrated entity within the Australian animal health sector, delivering a wide array of veterinary offerings and essential products to both livestock and companion animals across the nation. The organization is structured around key operational divisions, including its extensive network serving dairy and mixed animal practices, as well as specialized services for feedlot and pig industries. The company’s comprehensive suite of services encompasses veterinary wholesale operations, advanced diagnostic laboratories, the development of bespoke vaccines, robust logistics solutions, and various supplementary support functions. Apiam caters to a broad spectrum of animal health requirements, providing dedicated care for domestic pets, dairy herds, swine, poultry, beef feedlots, equine populations, and sheep, alongside specialized genetic services. Moreover, Apiam embraces modern technology to enhance its offerings, integrating telemedicine capabilities, innovative remote video examination tools, health management applications tailored for production animal systems, sophisticated benchmarking databases, and comprehensive herd management software. General animal health products are readily available through its eCommerce platforms. These services are predominantly delivered through its expansive network of animal veterinary clinics situated in rural and regional Australia. Founded in 1998 and headquartered in Bendigo, Australia, Apiam Animal Health has recently been engaged in a Scheme Implementation Deed with subsidiaries of Adamantem, with a proposal to take the company private, a transaction expected to conclude by February 2026. This follows a strategic reset program initiated to streamline operations and enhance sustainable returns.